Skip to main content

Welcome to the Affiliated Projects page!

                            To have your project(s) added, contact us @parcka@hsc.utah.edu

Jake Magel, PT, PHD, DSc, FAAOMPT

PT-IN-MIND

Study Overview

Most patients treated by outpatient physical therapists (PTs) have musculoskeletal pain and 1 in 3 use prescription opioids. About 25% of those with musculoskeletal pain who are prescribed opioids for 90 or more days may have opioid misuse (taking prescription opioids in ways other than prescribed). PTs, Primary Care Providers (PCP), addiction leaders and scholars advocate that PTs should play a greater role in screening and addressing patients with opioid misuse. Unknown are the PCPs attitudes toward PTs’ role, competency, and adequacy in addressing opioid misuse, the PCPs preferences for how PTs should screen and address opioid misuse and the strategies for PTs to communicate with PCPs about patients with suspected opioid misuse. PCPs coordinate and prescribe opioids for patients. Although unknown, PCPs may not favor PTs in identifying and/or addressing opioid misuse among their patients; strategies for how to communicate this condition in a collaborative way may improve communication between PTs and PCPs about opioid misuse. 

Study Aims:

Aim 1: Evaluate the attitudes of PCPs toward PTs (e.g., PTs’ adequacy and legitimacy in their role), addressing opioid misuse in outpatient physical therapy practice. We will use surveys and semi-structured interviews to understand PCPs attitudes toward PTs addressing opioid misuse. 

Aim 2: Determine the optimal strategies for PTs to work collaboratively with PCPs about patients with suspected opioid misuse. Semi-structured interviews with PCPs will be used to understand the optimal strategies for PTs to work collaboratively with PCPs to address opioid misuse. 

Aim 3: Develop a treatment manual for PTs to address and communicate opioid misuse using the results from Aims 1 and 2. We will develop an initial draft of a treatment manual followed by checking the manual with PCPs then finalize the manual. Our results will provide pilot data to test the effectiveness of PTs to address opioid misuse.

LEARN MORE

Elizabeth Siantz, PhD, MSW

    Adapting and Implementing a Chronic Disease Self-Management Program for persons with opioid use disorders and serious mental illness

    Study Overview

    People with opioid use disorder (OUD) have a high co-occurrence of serious mental illness (SMI) and other chronic diseases, and are often challenged by their clinical symptoms and social vulnerabilities. While primary care settings frequently treat patients with OUD and SMI, primary care providers have few tools to support this population in self-managing these complex health conditions. The Chronic Disease Self-Management programs (CDSMP) can improve disease management skills and behaviors of people with chronic diseases but have not been adapted for primary care patients with OUD and SMI. Un-adapted versions might lack relevance to this population and setting. In this research project, Dr. Siantz will address this implementation gap through the following specific aims 

    Aim 1: Adapt the CDSMP for adults with OUD, SMI, and chronic disease for implementation in primary care settings using the CIPF. With my mentors, I will develop a Community Advisory Board (CAB). We will collaboratively adapt the CDSMP to improve relevance for this population and setting by exploring contextual factors that impact program implementation. This Research Aim corresponds with my Career Aim 1: develop expertise in intervention adaptation especially as it relates to the OUD population and associated mental health and primary care needs. 

    Aim 2: Test the feasibility, acceptability, and initial impact of adapted CDSMP for persons with SMI and OUD in a primary care setting. I will randomize patients at two primary care sites to receive adapted CDSMP or primary care treatment as usual, study feasibility (e.g., program attendance), acceptability (e.g., participant satisfaction), and initial outcomes (e.g., patient activation). This Aim corresponds with my Career Aim 2: ac-quire training in clinical trial design and management in real-world settings. 

    Aim 3: Evaluate implementation process and context of the adapted CDSMP using RAPICE. I will conduct interviews with study participants and clinic staff to understand how the CDSMP compares to usual care, implementation barriers and facilitators, and how study site differences impacted implementation. This research Aim corresponds to my Career Aim 3: obtain advanced skills in intervention implementation qualitative evaluation methods, particularly the RAPICE method.

    Our Team

    Principal Investigator:  Elizabeth Siantz, PhD, MSW

    K01 Mentoring Team: Adam Gordan, MD, MPH (Primary Mentor); Leopoldo Cabassa, MSW. PhD  (co-mentor)

    K01 Advisory:  Angela Fagerline, PhD; Gerald Cochran, MSW, PhD; Lawrence Palinkas, PhD

    Research Assistant: Emily Rougelot, MSW candidate